Mesoblast
MESO
68 hedge funds and large institutions have $58.9M invested in Mesoblast in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 17 closing their positions.
480% more call options, than puts
Call options by funds: $22.4M | Put options by funds: $3.87M
55% more capital invested
Capital invested by funds: $37.9M → $58.9M (+$21M)
28% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 18
0.14% more ownership
Funds ownership: 2.72% → 2.86% (+0.14%)
6% less funds holding
Funds holding: 72 → 68 (-4)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Legal & General Group
London,
United Kingdom
|
+$9.53M |
| 2 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$2.93M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.45M |
| 4 |
Jane Street
New York
|
+$595K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$540K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.7M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$1.33M |
| 3 |
PM
Penbrook Management
New York
|
-$1.28M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.09M |
| 5 |
MG
Marex Group
London,
|
-$1.09M |
MESO Hedge Fund Activity: Q3 2025 in Review
68 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2025, worth a combined $58.9M — up 55% from $37.9M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of MESO and 13 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 23 added.
The largest buyer was Legal & General Group, opening a new position worth an estimated $9.53M. The largest seller was BlackRock, cutting an estimated $1.7M.
- 68 institutional investors held Mesoblast (MESO) as of Q3 2025, down from 72 in Q2 2025.
- Funds reported $58.9M of Mesoblast stock for Q3 2025, up 55% quarter-over-quarter.
- 13 funds opened new Mesoblast positions in Q3 2025 and 17 closed out, a net change of -4 holders.
- The largest Mesoblast buyer in Q3 2025 was Legal & General Group, an estimated $9.53M added.
- The largest Mesoblast seller in Q3 2025 was BlackRock, an estimated $1.7M sold.
Based on aggregated 13F filings for Q3 2025.